Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan
Shohei Yamamoto, Akihito Tanaka, Yusuke Oshiro, Masamichi Ishii, Hironori Ishiwari, Maki Konishi, Kouki Matsuda, Mitsuru Ozeki, Kengo Miyo, Kenji Maeda, Tetsuya Mizoue, Wataru Sugiura, Hiroaki Mitsuya, Haruhito Sugiyama, Norio Ohmagari
Topics & Concepts
SeroprevalenceMedicineInfection controlSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health careCoronavirus disease 2019 (COVID-19)PopulationCoronavirusDiseaseEnvironmental healthEmergency medicineImmunologyAntibodyInternal medicineIntensive care medicineSerologyInfectious disease (medical specialty)EconomicsEconomic growthSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies